Michael Hallett
Psychiatry · Amherst, NYNPI 1467455204
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 385 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,227 and has fallen 82.3% since, to $395 in 2023. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$930
- Alkermes, Inc.$820
- Sunovion Pharmaceuticals Inc.$641
- Lundbeck LLC$510
- Johnson & Johnson$495
- Otsuka America Pharmaceutical, Inc.$420
- plus $3K from 23 others
What the payments were for
- Food & beverage$6,458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $930 |
| Alkermes, Inc. | 36 | $820 |
| Sunovion Pharmaceuticals Inc. | 44 | $641 |
| Lundbeck LLC | 32 | $510 |
| Johnson & Johnson | 53 | $495 |
| Otsuka America Pharmaceutical, Inc. | 23 | $420 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $391 |
| Bausch Health US, LLC | 20 | $334 |
| Teva Pharmaceuticals USA, Inc. | 14 | $291 |
| Neurocrine Biosciences, Inc. | 12 | $214 |
| Vanda Pharmaceuticals Inc. | 11 | $213 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $168 |
| Merck | 9 | $159 |
| Eisai Inc. | 9 | $149 |
| Jazz Pharmaceuticals Inc. | 7 | $145 |
| Supernus Pharmaceuticals, Inc. | 4 | $126 |
| Avanir Pharmaceuticals, Inc. | 3 | $65 |
| Neos Therapeutics, LP | 3 | $64 |
| Alfasigma USA, Inc. | 4 | $57 |
| Almatica Pharma LLC | 3 | $50 |
| Tris Pharma Inc | 3 | $49 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Biogen | 1 | $27 |
| Neuronetics, Inc. | 2 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $16 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
How this compares
$6,458 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Amherst
- Adam AshtonAmherst$1.6M
- Horacio CapoteAmherst$1.1M
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Yadagiri ChepuruYonkers$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.